| Literature DB >> 21959281 |
Carl E Stafstrom1, Seden Grippon, Peter Kirkpatrick.
Abstract
Ezogabine (Potiga; Valeant Pharmaceuticals/GlaxoSmithKline), a potassium channel opener, was approved in June 2011 by the U.S. Food and Drug Administration (F.D.A.) for the adjunctive treatment of partial-onset seizures in adult patients. The same drug was granted marketing authorization for this indication in the European Union in March 2011, where it is known as retigabine (Trobalt).Entities:
Mesh：
Substances：
Year: 2011 PMID： 21959281 DOI： 10.1038/nrd3561
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694